ARCHIVES

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

This article is from The Cancer Letter archive.

Vol. 36 No. 33 | September 17, 2010

Download PDF Visit The Full Archive

Related Articles

New System Devised To Help Identify Emerging Comprehensive Centers

October 10, 1975

Urgent Need For New Drugs To Treat Pre-Cancers: AACR.

March 1, 2002

FDA Warns of Lymphoma Risk Associated With Breast Implants

January 28, 2011

UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says

September 24, 1999

Professional Societies: ACCI Selects UPCI To Manage Operations; Elects New Officers

December 3, 1999

NCI To Voluntarily Spends $196 Million On Breast Cancer; Will Require Reallocation

November 13, 1992